Skip to main content
OpenTrials

Clinical trial condition

Intestinal Diseases

Explore clinical trials studying Intestinal Diseases. Study availability and eligibility vary by location and protocol.

11,737 public trials 2,242 recruiting studies
Refine in advanced search Browse all conditions

Intestinal Diseases trial results

Active, Not Recruiting

Transmural Healing and Disease-Modifying Effect of Guselkumab in Crohn's Disease Patients

NCT06408935

Conditions
Crohn Disease, Crohn's Disease, Digestive System Diseases, +4 more
Locations
  • Center for Colitis and Crohns Disease University of California San Francisco, California, United States
  • The University of Chicago Medical Center (UCMC) Chicago, Illinois, United States
  • Washington University School Of Medicine St Louis, Missouri, United States
  • Medical University of South Carolina Charleston, South Carolina, United States
View all 84 locations
View Trial Details
Active, Not Recruiting

A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Ulcerative Colitis

NCT06260163

Conditions
Colitis, Colitis, Ulcerative, Colonic Diseases, +5 more
Locations
  • Children's Hospital Oakland Oakland, California, United States
  • Riley Hospital for Children Indianapolis, Indiana, United States
  • NYU Langone Health Lake Success, New York, United States
  • The Kids Research Institute Australia on behalf of the Centre for Child Health Research Nedlands, Australia
View all 61 locations
View Trial Details
Active, Not Recruiting

Vaccine Therapy in Treating Patients With Newly Diagnosed Advanced Colon Polyps

NCT02134925

Conditions
Colonic Diseases, Colorectal Adenoma, Colorectal Carcinoma, +12 more
Locations
  • Massachusetts General Hospital Cancer Center Boston, Massachusetts, United States
  • Mayo Clinic in Rochester Rochester, Minnesota, United States
  • Kansas City Veterans Affairs Medical Center Kansas City, Missouri, United States
  • Thomas Jefferson University Hospital Philadelphia, Pennsylvania, United States
View Trial Details
Active, Not Recruiting

Combination Chemotherapy With or Without Atezolizumab in Treating Patients With Stage III Colon Cancer and Deficient DNA Mismatch Repair

NCT02912559

Conditions
Colon Adenocarcinoma, Colonic Diseases, Colonic Neoplasms, +19 more
Locations
  • Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
  • Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
  • Alaska Oncology and Hematology LLC Anchorage, Alaska, United States
  • Alaska Women's Cancer Care Anchorage, Alaska, United States
View all 1050 locations
View Trial Details
Active, Not Recruiting

A Study of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Ulcerative Colitis

NCT05242484

Conditions
Colitis, Colitis, Ulcerative, Colonic Diseases, +5 more
Locations
  • Valley Gastroenterology Medical Group Arcadia, California, United States
  • Southern California Research Center Coronado, California, United States
  • Om Research LLC Lancaster, California, United States
  • Cedars Sinai Medical Center Los Angeles, California, United States
View all 403 locations
View Trial Details
Active, Not Recruiting

Testing the Addition of Atezolizumab to Combination Chemotherapy or Atezolizumab Alone for Metastatic Colon or Rectal Cancer, the COMMIT Study

NCT02997228

Conditions
Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, +10 more
Locations
  • Kingman Regional Medical Center Kingman, Arizona, United States
  • NEA Baptist Memorial Hospital and Fowler Family Cancer Center - Jonesboro Jonesboro, Arkansas, United States
  • Kaiser Permanente-Anaheim Anaheim, California, United States
  • Kaiser Permanente-Baldwin Park Baldwin Park, California, United States
View all 445 locations
View Trial Details
Active, Not Recruiting

A Long-term Extension Study of Ustekinumab in Pediatric Participants

NCT05092269

Conditions
Arthritis, Arthritis, Psoriatic, Bone Diseases, +19 more
Locations
  • Children's Center For Digestive Healthcare, Llc Atlanta, Georgia, United States
  • Mount Sinai New York, United States
  • Levine Childrens at Atrium Health Charlotte, North Carolina, United States
  • Pediatric Specialists Of Virginia Fairfax, Virginia, United States
View all 48 locations
View Trial Details
Active, Not Recruiting

Durvalumab and Tremelimumab With or Without High or Low-Dose Radiation Therapy in Treating Patients With Metastatic Colorectal or Non-small Cell Lung Cancer

NCT02888743

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +22 more
Locations
  • Mayo Clinic Hospital in Arizona Phoenix, Arizona, United States
  • Mayo Clinic in Arizona Scottsdale, Arizona, United States
  • Los Angeles General Medical Center Los Angeles, California, United States
  • USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
View all 42 locations
View Trial Details
Active, Not Recruiting

Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)

NCT02465060

Conditions
Adenocarcinoma, Adnexal Diseases, Advanced Lymphoma, +138 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Thomas Hospital Fairhope, Alabama, United States
  • Mobile Infirmary Medical Center Mobile, Alabama, United States
  • University of South Alabama Mitchell Cancer Institute Mobile, Alabama, United States
View all 1411 locations
View Trial Details

Related conditions